TCL Archive User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations” January 20, 1989
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar January 10, 2003
